📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-18 19:31
343 analysed today
343
Today
133,232
All-time analysed
40,094
Positive
6,279
Negative
79,048
Neutral
7,743
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
29 announcements match the current filters (relevance ≥ 5).
Manorama Ind Q1 FY27 Concall: PAT jumps 67.6% YoY to ₹79 Cr, Revenue reaches ₹404 Cr
Manorama Industries published its Q1 FY27 earnings conference call transcript, discussing strong operational momentum with quarterly revenue growing 39.5% YoY to ₹404 crore. EBITDA rose 42.2% YoY to ₹106 crore (margin at 26.3%), while PAT surged 67.6% YoY to ₹79 crore (margin at 19.5%). Management highlighted expansion initiatives, including acquiring ~10 hectares (24 acres) in Burkina Faso for shea/mango processing and establishing a subsidiary in Chad. Export to domestic revenue mix stood at 60:40, while other income included ₹13 crore of forex gains.
Confidence: HIGH
What changedManorama Industries released the official verbatim transcript of its Q1 FY27 earnings conference call held on August 14, 2026.
Why it mattersProvides management commentary on sourcing integration in West Africa, margin sustainability, and utilization ramp-up of the expanded fractionation capacities.
Q1 FY27 Revenue: ₹404 CrQ1 FY27 PAT: ₹79 CrEBITDA Margin: 26.3%Burkina Faso Land Acquired: 10 hectares (24 acres)Forex Gain in Other Income: ₹13 Cr
📅 Short termConfirms strong quarterly financial trajectory and stable operating performance post recent QIP fundraise and capacity expansion.
📈 Long termBackward integration into West African sourcing and capacity expansion in specialty fats should support long-term margins and market share gains in global cocoa butter alternatives.
⚠ Risk flags
- Raw material seasonality and supply chain exposure to West Africa
- ₹13 Cr of Q1 PAT supported by forex gains included in other income
Key Highlights
Revenue crossed ₹404 crore in Q1 FY27, up 39.5% YoY, driven by higher fractionation plant utilization
EBITDA increased 42.2% YoY to ₹106 crore with EBITDA margin expanding by 49 bps to 26.3%
PAT surged 67.6% YoY to ₹79 crore, with net margin improving 326 bps to 19.5%
Acquired ~10 hectares (24 acres) in Burkina Faso for a shea and mango nut processing facility
Other income of ₹16 crore included ₹13 crore in forex gains
👀 What to Watch
Track execution and regulatory approvals for the Burkina Faso and Raipur processing facilities, alongside volume ramp-up from the 52,000 MT total capacity.
Manorama Industries Plans ₹460 Cr Capex; Fractionation Capacity Reaches 47,500 MTPA
Manorama Industries has outlined a significant growth roadmap in its Q1FY27 presentation, following a strong FY26 where revenue reached ₹1,367 Cr with a 46.2% ROCE. The company has expanded its fractionation capacity to 47,500 MTPA as of Q1FY27 and is targeting 52,000 MTPA within the current fiscal year. A major ₹460 Cr capex plan (approx. 34% of TTM revenue) is proposed over the next 2-3 years to add a 75,000 TPA fractionation plant and a processing facility in Burkina Faso. The company maintains a high-efficiency model with a 7.4x asset turnover and a 60:40 export-domestic revenue mix.
Confidence: HIGH
What changedThe company has transitioned from its previous capacity expansion phase (25,000 MTPA added in 2024) to a new ₹460 Cr investment cycle focused on global backward integration and a third fractionation plant.
Why it mattersThe expansion targets the high-margin Cocoa Butter Equivalent (CBE) market where regulatory support (up to 5% usage in chocolate) and demand for sustainable cosmetic ingredients are driving growth.
Proposed Capex: ₹460 CrCapex vs TTM Revenue: 33.65%Current Fractionation Capacity: 47,500 MTPAFY26 ROCE: 46.2%Asset Turnover (FY26): 7.4xExport Revenue Mix (Q1FY27): 60%
📅 Short termThe market is likely to react positively to the high capital efficiency (ROCE) and the clear roadmap for tripling fractionation capacity compared to FY22 levels.
📈 Long termStructural growth is supported by the shift toward value-added specialty fats and global sourcing hubs, potentially sustaining the 40% expected growth rate over the next 2-3 years.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk of large-scale capex
- Raw material seasonality (15-20% supply risk)
- Geopolitical risks in West African sourcing regions
Key Highlights
Proposed ₹460 Cr capex over 2-3 years for expanding CBA manufacturing and solvent fractionation.
Fractionation capacity increased to 47,500 MTPA in Q1FY27, with a target of 52,000 MTPA in FY27.
Achieved a standalone asset turnover of 7.4x in FY26, up from 5.0x in FY22.
Delivered a 48.5% Revenue CAGR and 76.2% PAT CAGR between FY22 and FY26.
Strategic expansion into Brazil with partner DEKEL saw first commercial production in Q3FY26.
👀 What to Watch
Watch for the board's final approval and execution timeline of the ₹460 Cr capex, specifically the commissioning of the Burkina Faso facility which is key for raw material security.
67.6% PAT Growth: Manorama Industries Crosses Rs 400 Cr Quarterly Revenue Milestone
Manorama Industries delivered a robust Q1 FY27, with revenue increasing 39.5% YoY to Rs 404.01 Cr, surpassing the Rs 400 Cr quarterly milestone for the first time. Net profit surged 67.6% YoY to Rs 78.66 Cr, supported by a 326 bps expansion in PAT margins to 19.5%. The company is strengthening its global supply chain by acquiring 24 acres in Burkina Faso and establishing a new subsidiary in Chad for Shea sourcing. Export revenue remains the primary driver, contributing 60% of the total revenue mix.
Confidence: HIGH
What changedThe company achieved its highest-ever quarterly revenue and significantly improved its bottom-line margins while expanding its physical sourcing footprint in West Africa.
Why it mattersThe results validate the company's ability to scale its specialty fats business while maintaining high margins (26% EBITDA) and securing its raw material supply chain through backward integration.
Q1 FY27 Revenue: Rs 404.01 CrYoY PAT Growth: 67.6%EBITDA Margin: 26.3%Export Revenue Share: 60%Land Acquired (Burkina Faso): 24 acres
📅 Short termPositive market reaction is expected as the earnings significantly exceeded the previous year's run rate and margins showed sequential improvement.
📈 Long termStructural growth remains strong as the company integrates its African supply chain and targets higher-value segments like ethical beauty and luxury products.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical risks in West African sourcing regions
- Seasonality of forest-based raw material collection
- Regulatory approvals pending for the Burkina Faso project
Key Highlights
Revenue reached a record Rs 404.01 Cr, up 39.5% YoY from Rs 289.55 Cr in Q1 FY26.
PAT surged 67.6% YoY to Rs 78.66 Cr, significantly outperforming revenue growth due to operating leverage.
EBITDA margins expanded to 26.3%, a 49 bps increase YoY and 138 bps increase QoQ.
Acquired ~10 hectares (24 acres) of land in Burkina Faso for a new Shea seed processing facility.
Export-to-Domestic revenue mix stood at 60:40, reflecting strong international demand for specialty fats.
👀 What to Watch
Monitor the execution timeline for the Burkina Faso facility and the utilization levels of the 52,000 MT capacity, which management targets for Rs 1,800-2,000 Cr in annual revenue.
67.6% YoY PAT Growth in Q1 FY27; Revenue reaches Rs 404 Cr
Manorama Industries reported a strong start to FY27, with consolidated revenue growing 39.5% YoY to Rs 404.01 Cr. Net profit surged 67.6% YoY to Rs 78.66 Cr, significantly outperforming the previous year's Q1 profit of Rs 46.94 Cr. The growth is likely driven by the ramp-up of the 25,000 MT fractionation plant commissioned in mid-2024. While standalone operations are highly profitable, the company's nine global subsidiaries reported a combined net loss of Rs 2.93 Cr for the quarter.
Confidence: HIGH
What changedThe company has reported its Q1 FY27 financial results, showing a substantial jump in both revenue and profitability compared to the same period last year.
Why it mattersThe results validate the company's expansion strategy and its ability to maintain high margins (OPM ~30% this quarter) despite scaling operations in the specialty fats and butters segment.
Consolidated Revenue (Q1 FY27): Rs 404.01 CrConsolidated Net Profit (Q1 FY27): Rs 78.66 CrYoY Revenue Growth: 39.5%YoY PAT Growth: 67.6%Subsidiary Net Loss: Rs 2.93 Cr
📅 Short termThe stock is likely to react positively in the short term due to the significant earnings beat and margin expansion compared to the TTM average.
📈 Long termThe company is structurally well-positioned to benefit from its increased capacity and focus on high-margin 'Ethical Beauty' segments, supporting its 40% growth guidance.
⚠ Risk flags
- Losses in global subsidiaries
- Seasonality in raw material collection
- High valuation with a P/E of 46.1
Key Highlights
Consolidated revenue from operations increased 39.5% YoY to Rs 404.01 Cr from Rs 289.55 Cr.
Consolidated Net Profit grew 67.6% YoY to Rs 78.66 Cr compared to Rs 46.94 Cr in Q1 FY26.
Earnings Per Share (EPS) for the quarter rose to Rs 13.17 from Rs 7.87 YoY.
Profit Before Tax (PBT) margin stood at 26.3% of total income, reflecting strong operational efficiency.
The board fixed September 14, 2026, as the cut-off date for the final dividend and AGM voting.
👀 What to Watch
Monitor the company's progress toward its Rs 1,800-2,000 Cr revenue target at 100% capacity utilization and track the turnaround of international subsidiaries.
₹20.64 Cr voluntary customs duty payment by Manorama Industries following UAE import inquiry
Manorama Industries has voluntarily deposited ₹20.64 Cr with Customs authorities following an inquiry into preferential tariff claims under the India-UAE CEPA. The inquiry, initiated by the Special Intelligence & Investigation Branch (SIB) Indore, concerns the eligibility of Palm Mid Fraction imports for lower duties. The company has paid the full differential duty, interest, and penalties to avoid further litigation while issuing a debit note to its UAE supplier to recover the amount. This one-time payment represents approximately 9.8% of the company's TTM PAT and 3% of its Net Worth.
Confidence: HIGH
What changedThe company has transitioned from a preferential tariff regime to paying full customs duty for specific past imports and has initiated a legal recovery process against its overseas supplier.
Why it mattersThe ₹20.64 Cr outflow is a material one-time hit to liquidity and earnings, representing nearly 10% of annual profits, and highlights compliance risks in international sourcing.
Total Voluntary Deposit: ₹20.64 CrDeposit vs TTM PAT: ~9.8%Deposit vs Net Worth: ~3.0%Differential Customs Duty: ₹16.95 CrPenalty Component: ₹1.03 Cr
📅 Short termThe stock may face minor pressure due to the one-time cash outflow and the disclosure of a regulatory inquiry, though the voluntary nature of the payment reduces litigation uncertainty.
📈 Long termLimited structural impact if the company successfully recovers the amount from the supplier or adjusts its sourcing documentation to comply with CEPA requirements.
⚠ Risk flags
- Regulatory scrutiny
- Supplier dispute
- One-time earnings hit
- Potential loss of preferential tariff benefits
Key Highlights
Voluntary deposit of ₹20,64,17,893 made on July 29, 2026, following a summons received on July 24, 2026.
Breakdown of payment includes ₹16.95 Cr in differential customs duty and ₹1.03 Cr in penalties.
Company issued a debit note and legal notice to the UAE supplier on August 10, 2026, for full recovery.
The dispute centers on Certificates of Origin for Palm Mid Fraction, a key raw material for specialty fats.
Management states no further material adverse impact is anticipated on operations beyond this deposit.
👀 What to Watch
Monitor the success of the recovery action against the UAE supplier and check for any impact on gross margins in upcoming quarters if preferential tariff benefits are permanently discontinued for these imports.
Manorama Industries Incorporates New Subsidiary in Republic of Chad with CFA 1 Cr Capital
Manorama Industries has incorporated a wholly-owned subsidiary, Manorama Savannah Agro Chad SARL, in the Republic of Chad on July 20, 2026. The new entity has an authorized and paid-up capital of CFA 10,000,000 (approximately ₹13.7 Lakhs) and will focus on trading in the food and cosmetic industries. This move aligns with the company's strategy to leverage global subsidiaries for sourcing and market expansion in West Africa. While the initial investment is small, it supports the company's goal of reaching 100% utilization of its 52,000 MT capacity.
Confidence: HIGH
What changedManorama Industries has established a direct legal presence in the Republic of Chad through a new wholly-owned subsidiary.
Why it mattersDirect presence in West Africa is crucial for securing forest-based raw materials like Shea, reducing supply chain risks and supporting the utilization of the company's 52,000 MT fractionation capacity.
Subsidiary Paid-up Capital: CFA 10,000,000Parent TTM Revenue: ₹1367 CrInstalled Capacity: 52,000 MTOwnership Stake: 100%
📅 Short termMinimal immediate impact on stock price as the capital investment is small relative to the company's ₹9,558 Cr market cap.
📈 Long termStrategically significant for securing the supply chain in a key sourcing region, which is essential for long-term margin stability and growth in the specialty fats segment.
⚠ Risk flags
- Geopolitical risks in the Republic of Chad
- Sourcing disruptions in West Africa
Key Highlights
Incorporation of 100% Wholly Owned Subsidiary 'MANORAMA SAVANNAH AGRO CHAD SARL' on July 20, 2026
Initial authorized and paid-up capital of CFA 10,000,000 (CFA 1 Crore)
Subsidiary to focus on trading within the Food & Cosmetic Industry
Strategic expansion into West Africa to support raw material sourcing for specialty fats
Move supports the company's target to scale revenue to ₹1,150 Cr+ in FY26
👀 What to Watch
Monitor how this subsidiary improves raw material sourcing efficiency from West Africa, which is a critical factor for maintaining the company's 25.3% operating margins.
Manorama to incorporate Wholly Owned Subsidiary in Chad with CFA 1 Cr capital
Manorama Industries has approved the incorporation of a new wholly-owned subsidiary (WOS) in Chad, named Manorama Savannah Agro Chad SARL. The entity will focus on the procurement, processing, and sale of shea nuts and butter, which are critical raw materials for the company's specialty fats business. With an initial capital of CFA 1,00,00,000 (approximately ₹13.7 Lakhs), the investment is small relative to the company's ₹9,054 Cr market cap but strategically significant. This move aligns with the company's goal to secure its supply chain in West Africa and support its target of reaching ₹1,150 Cr+ revenue in FY26.
Confidence: HIGH
What changedManorama is formalizing its presence in Chad by establishing a dedicated legal entity for raw material sourcing and processing.
Why it mattersDirect presence in West Africa is crucial for securing shea nuts, a key ingredient for their high-margin specialty fats and 'Ethical Beauty' segments, reducing reliance on third-party sourcing.
Initial Capital: CFA 1,00,00,000Shareholding: 100%TTM Revenue: ₹1367 CrCurrent Capacity: 52,000 MTFY26 Revenue Target: ₹1,150 Cr+
📅 Short termThe announcement is likely to be viewed positively as a sign of strategic execution, though the immediate financial impact is negligible due to the small initial capital.
📈 Long termStructurally positive as it strengthens backward integration and supply chain resilience in a key sourcing region, supporting the company's 40% expected growth rate.
⚠ Risk flags
- Geopolitical and regulatory risks in Chad
- Execution risk in setting up processing infrastructure
- Seasonality of forest-based raw material collection
Key Highlights
Incorporation of 100% Wholly Owned Subsidiary in Chad named Manorama Savannah Agro Chad SARL
Initial authorized and paid-up capital set at CFA 1,00,00,000
Primary business objective includes buying, processing, and selling shea nuts and butter
Move supports the company's strategy to leverage 8 global subsidiaries for raw material sourcing
Investment to be made in one or more tranches as per business requirements
👀 What to Watch
Monitor the operational timeline for the Chad facility and its impact on raw material sourcing costs, particularly how it mitigates the 15-20% supply reduction typically seen in off-peak quarters.
₹500 Cr QIP Allotment Completed at ₹1,470 per Share
Manorama Industries has successfully completed a ₹500 crore Qualified Institutions Placement (QIP), allotting 34.01 lakh shares to institutional investors. The issue price of ₹1,470 per share includes a 4.99% discount to the floor price. This capital infusion is highly material, representing approximately 72% of the company's existing net worth of ₹695 crore and about 5.3% of its current market capitalization. High-profile allottees include ValueQuest funds (35% combined), Abu Dhabi Investment Authority (6.44%), and WhiteOak Capital.
Confidence: HIGH
What changedThe company has successfully raised ₹500 crore in fresh equity capital, increasing its paid-up share capital from ₹11.94 crore to ₹12.62 crore.
Why it mattersThis massive capital infusion significantly strengthens the balance sheet, providing the necessary liquidity to fund aggressive capacity utilization and global expansion targets without increasing debt levels.
Total Fundraise: ₹500 CrFundraise vs Net Worth: ~72%Issue Price: ₹1,470Equity Dilution: ~5.4%Discount to Floor Price: 4.99%
📅 Short termThe successful pricing and participation by marquee institutional investors like ADIA and Goldman Sachs are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe capital supports the company's structural growth plan to leverage its 52,000 MT capacity and expand into luxury cosmetic segments, potentially re-rating the business if execution targets are met.
⚠ Risk flags
- Equity dilution of ~5.4%
- Execution risk in deploying large capital efficiently to maintain high ROCE
Key Highlights
Raised ₹500 crore through the allotment of 34,01,360 equity shares at ₹1,470 each
Fundraise magnitude is significant at ~72% of the company's current net worth of ₹695 crore
Equity dilution stands at approximately 5.4% of the post-issue share capital
Top allottees include VQ Fastercap Fund (20%) and ValueQuest India Inflexion Fund (15%)
Issue price includes a premium of ₹1,468 per share on a face value of ₹2
👀 What to Watch
Investors should monitor the deployment of these funds toward the company's stated goal of scaling revenue to ₹1,150 Cr+ in FY26 and expanding into high-margin ethical beauty segments.
₹500 Cr QIP Closure: Manorama Industries Allocates 34.01 Lakh Shares at ₹1,470 Each
Manorama Industries has successfully closed its Qualified Institutions Placement (QIP), raising approximately ₹500 crore. The company allocated 34,01,360 equity shares at an issue price of ₹1,470 per share, which includes a 4.99% discount to the floor price. This capital infusion is highly material, representing approximately 72% of the company's current net worth (₹695 Cr) and will result in an equity dilution of roughly 5.7%. The funds are expected to support the company's target of scaling revenue to ₹1,150 Cr+ in FY26.
Confidence: HIGH
What changedThe company has completed a major institutional fundraise, significantly strengthening its cash position and equity base.
Why it mattersThis provides the necessary capital to fuel the company's 40% growth guidance and expansion into luxury segments without increasing its debt-to-equity ratio (currently 0.51).
Total Fundraise Amount: ₹500 CrIssue Price: ₹1,470Fundraise vs Net Worth: ~72%Shares Allocated: 34,01,360Discount to Floor Price: 4.99%
📅 Short termThe successful institutional interest and capital infusion are likely to be viewed positively by the market, though the 5% discount to the floor price may lead to short-term price alignment.
📈 Long termThe capital significantly de-risks the company's expansion plans and provides the liquidity needed to scale operations toward its ₹1,800-2,000 Cr revenue potential at full capacity utilization.
⚠ Risk flags
- Equity dilution of approximately 5.7%
- Execution risk in deploying large capital to meet high growth targets
Key Highlights
Raised approximately ₹500 crore through the issuance of 34,01,360 equity shares
Issue price fixed at ₹1,470 per share, representing a 4.99% discount to the floor price of ₹1,547.18
Fundraise magnitude is significant at ~72% of the company's reported net worth of ₹695 Cr
The QIP issue was open for 4 days, from June 29, 2026, to July 02, 2026
Equity dilution from this issuance is estimated at approximately 5.7% of the post-issue capital
👀 What to Watch
Investors should monitor the deployment of these funds toward the 52,000 MT capacity utilization and the expansion into high-margin 'Ethical Beauty' segments as guided by management.
₹1,547.18 Floor Price: Manorama Industries Launches QIP Fundraise
Manorama Industries has officially launched its Qualified Institutions Placement (QIP) on June 29, 2026. The board has set the floor price at ₹1,547.18 per share, which is a 3.97% discount to the current market price of ₹1,611.2. The company has the discretion to offer an additional discount of up to 5% to institutional investors. This capital raise follows a shareholder approval from April 2026 and is aimed at supporting the company's aggressive growth targets, including a revenue goal of ₹1,150 Cr+ for FY26.
Confidence: HIGH
What changedThe company has transitioned from the approval phase to the execution phase of its institutional fundraise (QIP).
Why it mattersThe fundraise will provide the necessary capital to scale operations toward the company's ₹1,800-2,000 Cr revenue potential at full capacity utilization, while potentially impacting the current debt-to-equity ratio of 0.51.
Floor Price: ₹1,547.18Current Market Price (CMP): ₹1,611.2Floor Price vs CMP: 3.97% discountMax Permissible Discount: 5%TTM Revenue: ₹1,367 CrMarket Cap: ₹9,619 Cr
📅 Short termThe stock price may experience volatility and potentially align closer to the final QIP allotment price over the coming weeks.
📈 Long termIf successfully deployed into high-margin 'Ethical Beauty' and luxury segments, this capital could support the management's 40% expected growth rate and high ROCE (currently 35%).
⚠ Risk flags
- Equity dilution for existing shareholders
- Utilization of proceeds risk
- Market volatility during the issue period
Key Highlights
Floor price for the QIP set at ₹1,547.18 per equity share.
The issue officially opened on June 29, 2026, following board and shareholder approvals.
Company may offer a maximum discount of 5% on the calculated floor price.
The fundraise follows a period of strong growth, with TTM revenue reaching ₹1,367 Cr.
👀 What to Watch
Investors should watch for the final issue price and the total amount of capital raised to calculate the exact equity dilution. Monitor subsequent filings for the specific allocation of funds toward the 52,000 MT capacity utilization or new product segments.
Manorama Industries FY26 Revenue Surges 76.1% to ₹1,358 Cr; PAT at ₹233.2 Cr
Manorama Industries delivered exceptional FY26 performance with revenue growing 76.1% YoY to INR 1,358 crores, driven by strong volume growth in specialty fats. The company maintained high profitability with an EBITDA margin of 27.1% and reported a PAT of INR 233.2 crores. Operational efficiency improved as the working capital cycle reduced to 125 days from 151 days, resulting in a strong operating cash flow of INR 259.4 crores. Management outlined a strategic capex plan of INR 460 crores over the next 2-3 years to expand capacity and integrate backward in West Africa.
Key Highlights
FY26 Revenue increased 76.1% YoY to INR 1,358 crores with a PAT margin of 17.2%.
EBITDA for the full year stood at INR 367.7 crores with a healthy margin of 27.1%.
Return on Equity (ROE) and Return on Capital Employed (ROCE) reached 40.3% and 33.6% respectively.
Announced INR 460 crore capex for a new fractionation facility, refinery expansion, and a Burkina Faso processing unit.
Working capital cycle improved significantly to 125 days, boosting net cash flow from operations to INR 259.4 crores.
👀 What to Watch
Investors should maintain a positive outlook given the company's robust growth trajectory, high return ratios, and clear expansion roadmap. Monitor the execution of the Burkina Faso project as it is expected to further optimize logistics costs and margins.
Manorama Industries FY26 PAT Surges 108.1% to INR 2,332 Mn; Proposes Final Dividend
Manorama Industries delivered an exceptional performance for FY26, with revenue increasing by 76.1% YoY to INR 13,577 Mn, driven by a favorable product mix and higher capacity utilization. EBITDA grew 92.5% YoY to INR 3,677 Mn, with margins expanding by 230 bps to 27.1%. Net profit (PAT) surged by 108.1% YoY to INR 2,332 Mn, reflecting high capital efficiency as annual cash profit exceeded its gross block. The company also announced a strategic capex plan of INR 460 crores over the next 2-3 years and a final dividend of INR 0.80 per share.
Key Highlights
FY26 Revenue grew 76.1% YoY to INR 13,577.0 Mn, with a Domestic to Export mix of 43:57.
FY26 EBITDA increased by 92.5% YoY to INR 3,677.1 Mn; EBITDA margin expanded by 230 bps to 27.1%.
FY26 PAT surged 108.1% YoY to INR 2,332.2 Mn, though Q4 FY26 PAT fell 12.8% QoQ due to foreign exchange provisions.
Planned strategic capex of approximately INR 460 crores over the next 2-3 years for forward/backward integration and global expansion.
Board recommended a final dividend of INR 0.80 per equity share (40% of face value of INR 2).
👀 What to Watch
Investors should view this as a highly positive earnings report demonstrating robust growth and strong capital efficiency. The planned INR 460 crore capex provides strong visibility for future growth, though short-term currency fluctuations should be monitored.
Manorama Industries: ₹0.80 Dividend & ₹350 Cr Investment for Burkina Faso Factory
Manorama Industries has recommended a final dividend of ₹0.80 per share for FY26, representing 40% of the face value. The company is undertaking a major international expansion by setting up a processing factory in Burkina Faso through its subsidiary, Taang Kaam Industries SA. To support this, the board has approved a total financial package of up to ₹350 Crore, including equity, loans, and guarantees. Additionally, the company corrected a clerical error in its previously filed FY26 audited results, which received a clean audit opinion.
Key Highlights
Recommended a final dividend of ₹0.80 per equity share (40% of ₹2 face value) for FY 2025-26.
Approved equity investment of up to ₹150 Crore in subsidiary Taang Kaam Industries SA for a new factory.
Authorized additional financial support of up to ₹200 Crore through unsecured loans and corporate guarantees.
Statutory auditors issued an unmodified (unqualified) opinion for the FY26 financial results.
Re-appointed CLA Indus Value Consulting and M/s. S N & Co. as internal and cost auditors for FY 2026-27.
👀 What to Watch
The significant capital commitment for the Burkina Faso project signals aggressive growth plans; investors should monitor the execution timeline and potential impact on debt levels.
Manorama Industries FY26 Revenue Jumps 76% to ₹1,358 Cr; Plans ₹460 Cr Strategic Capex
Manorama Industries reported a robust 76.1% YoY revenue growth to ₹1,358 Crores for FY26, driven by strong demand in the food and cosmetics sectors. The company achieved a significant milestone with annual cash profit of ₹258.77 Crore, which now exceeds its gross block of ₹250.85 Crore, indicating high capital efficiency. A strategic capex of ₹460 Crores is planned over the next 2-3 years for expansion, including a new manufacturing facility and a processing plant in Burkina Faso. The Board recommended a final dividend of ₹0.80 per share while reporting an improved working capital cycle of 125 days.
Key Highlights
Revenue grew 76.1% YoY to ₹1,358 Crores in FY26
Cash profit of ₹258.77 Crore surpassed the total Gross Block of ₹250.85 Crore
Planned strategic capex of ₹460 Crores for capacity expansion and global integration
Working capital cycle improved to 125 days with operating cash flow of ₹259 Crores
SF 2 capacity increased by 30% to 32,500 TPA via debottlenecking
👀 What to Watch
Investors should favor the company's high capital efficiency and aggressive growth roadmap in specialty fats. Monitor the execution of the ₹460 Cr capex and its impact on future margins.
Manorama Industries FY26 PAT Surges 108% to ₹233 Cr; Announces ₹460 Cr Capex Plan
Manorama Industries delivered a stellar FY26 performance with revenue growing 76.1% YoY to INR 13,577 Mn and PAT doubling to INR 2,332.2 Mn. The company achieved significant margin expansion, with EBITDA margins rising 230 bps to 27.1% driven by a better product mix and higher capacity utilization. A final dividend of INR 0.80 per share was declared, and the company outlined a robust INR 460 crore capex plan for the next 2-3 years to fuel future growth. Operational efficiency was highlighted by cash profits exceeding the gross block, indicating high capital efficiency.
Key Highlights
FY26 PAT surged 108.1% YoY to INR 2,332.2 Mn, while Revenue grew 76.1% to INR 13,577.0 Mn
EBITDA margins expanded by 230 bps YoY to 27.1% for the full year FY26
Announced a strategic capex of ~INR 460 crores over 2-3 years for backward integration and global expansion
Increased SF 2 plant capacity by 30% to 32,500 TPA and improved working capital cycle to 125 days
Board recommended a final dividend of INR 0.80 per equity share (40% of face value)
👀 What to Watch
Investors should view the strong earnings growth and high capital efficiency as positive indicators of the company's niche market leadership. The planned capex and capacity expansions suggest a strong growth runway, though monitoring the execution of the Burkina Faso plant and forex volatility is advised.
Manorama Industries to Invest Rs 150 Cr in Burkina Faso Factory; Recommends Rs 0.80 Dividend
Manorama Industries has announced a major international expansion, approving a proposal to set up a processing factory in Burkina Faso through its subsidiary, Taang Kaam Industries SA. The company plans to provide financial support up to Rs 350 crore, including Rs 150 crore in equity, Rs 100 crore in loans, and Rs 100 crore in guarantees. Additionally, the board recommended a final dividend of Rs 0.80 per share (40% of face value) for FY 2025-26. The annual audited results were released with an unmodified opinion from the statutory auditors, signaling stable governance.
Key Highlights
Approved equity investment of up to Rs 150 crore for a new processing factory in Burkina Faso.
Authorized additional financial assistance via unsecured loans (up to Rs 100 crore) and bank guarantees (up to Rs 100 crore).
Recommended a final dividend of Rs 0.80 per equity share of Rs 2 face value for FY 2025-26.
Statutory auditors Singhi & Co. issued an unqualified audit report for the financial year ended March 31, 2026.
Re-appointed CLA Indus Value Consulting and M/s. S N & Co. as Internal and Cost Auditors respectively for FY 2026-27.
👀 What to Watch
Investors should view the Burkina Faso expansion as a significant long-term growth driver, though they should monitor the execution risks of international projects. The 40% dividend payout and clean audit report reflect healthy financial discipline and shareholder focus.
Manorama Industries Recommends ₹0.80 Dividend; Approves ₹150 Cr Burkina Faso Expansion
Manorama Industries has recommended a final dividend of ₹0.80 per share (40% of face value) for FY26. The board has approved a major strategic expansion to set up a processing factory in Burkina Faso through its subsidiary, Taang Kaam Industries SA. This involves a capital commitment of up to ₹150 crore in equity and additional financial support of up to ₹200 crore via loans and guarantees. The company also cleared its audited FY26 financial results with an unmodified audit opinion.
Key Highlights
Recommended a final dividend of ₹0.80 per equity share of ₹2 face value for FY 2025-26.
Approved equity investment of up to ₹150 crore in subsidiary Taang Kaam Industries SA for a new factory in Burkina Faso.
Authorized unsecured loans up to ₹100 crore and corporate guarantees/SBLC up to ₹100 crore for the subsidiary.
Audited financial results for FY26 approved with an unqualified opinion from statutory auditors Singhi & Co.
Re-appointed CLA Indus Value Consulting as internal auditors and M/s. S N & Co. as cost auditors for FY27.
👀 What to Watch
Investors should take note of the significant capital outlay for the African expansion which signals long-term growth intent in raw material sourcing. The dividend provides a steady return while the company scales its global processing capabilities.
Manorama Industries Recommends Rs 0.80 Dividend & Approves Rs 350 Cr Burkina Faso Expansion
Manorama Industries has recommended a final dividend of Rs. 0.80 per share for FY26, representing 40% of the face value. The board has approved a major international expansion, authorizing up to Rs. 350 crore in financial support for a new processing factory in Burkina Faso. This support includes an equity infusion of up to Rs. 150 crore and debt/guarantee facilities totaling Rs. 200 crore. The move aims to strengthen the company's supply chain and production capabilities through its wholly-owned subsidiary, Taang Kaam Industries SA.
Key Highlights
Recommended final dividend of Rs. 0.80 per equity share (40% of face value) for FY26.
Approved equity investment of up to Rs. 150 crore in subsidiary Taang Kaam Industries SA for a new factory.
Authorized unsecured loans up to Rs. 100 crore and guarantees/SBLC up to Rs. 100 crore for the Burkina Faso project.
FY26 annual audited financial results received an unmodified (unqualified) opinion from statutory auditors.
Re-appointed CLA Indus Value Consulting and M/s. S N & Co. as internal and cost auditors for FY27.
👀 What to Watch
The expansion into Burkina Faso is a significant growth move that could secure raw material supply; investors should track the project's commissioning timeline. The dividend recommendation reflects management's confidence in the company's financial health despite the large capital commitment.
Manorama Industries Shareholders Approve INR 500 Crore Fundraise via QIP
Shareholders of Manorama Industries have approved a special resolution to raise up to INR 500 crore through Qualified Institutions Placement (QIP) or other permissible modes. The proposal received overwhelming support with 99.82% of votes cast in favor. This capital infusion is expected to fuel the company's growth initiatives and expansion plans. The resolution was officially passed following the conclusion of the postal ballot e-voting on April 19, 2026.
Key Highlights
Approved fundraise of up to INR 500 crore in one or more tranches via QIP or other securities.
Special resolution passed with a significant majority of 99.82% (4,11,77,725 votes) in favor.
Only 0.17% of votes (72,928 shares) were cast against the proposal.
Promoter and Promoter Group showed 100% support for the resolution with 3,24,33,406 votes.
👀 What to Watch
Investors should monitor the timing and pricing of the potential QIP, as it will indicate the level of institutional interest and the extent of equity dilution. The strong mandate reflects high shareholder confidence in the company's capital allocation plans.
Manorama Industries Credit Rating Upgraded to CARE A+; Stable for Rs 577.90 Cr Facilities
Care Edge Ratings has upgraded the credit rating for Manorama Industries Limited's long-term bank facilities to CARE A+; Stable from CARE A; Stable. The facility limit has been enhanced to Rs 577.90 Crore from Rs 492.90 Crore. Furthermore, the short-term rating for Rs 105 Crore of facilities was upgraded to CARE A1+ from CARE A1. This upgrade indicates a stronger financial profile and improved ability to service debt, which is a positive sign for long-term stakeholders.
Key Highlights
Long-term rating upgraded to CARE A+; Stable for facilities worth Rs 577.90 Crore.
Short-term rating upgraded to CARE A1+ for facilities worth Rs 105.00 Crore.
Total long-term facility limit increased by Rs 85 Crore to Rs 577.90 Crore.
Short-term facility limit significantly expanded from Rs 10 Crore to Rs 105 Crore.
👀 What to Watch
This upgrade validates the company's improving financial health and may lead to reduced borrowing costs. Investors should maintain a positive outlook on the stock's stability.
